Patents Assigned to BLUESTONE PHARMA GMBH
  • Patent number: 12714731
    Abstract: Provided is a method of producing a freeze-dried probiotic composition as well as a method of producing a probiotic raw material which involves culturing of a Streptococcus salivarius strain. Furthermore, a corresponding probiotic composition and a corresponding probiotic raw material is provided.
    Type: Grant
    Filed: March 1, 2024
    Date of Patent: August 25, 2026
    Assignees: BLUESTONE PHARMA GMBH, BLIS TECHNOLOGIES LIMITED
    Inventors: Elisabeth Kirl, Bernhard Hofbauer, Michael Faber, Karsten Brandt